Gregory P. Hanson, CHIEF FINANCIAL OFFICER, SECR at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX), sold 116,479 shares at $0.96 ($113K) on 2018-01-10, disclosed to the SEC on 2018-01-16.
Open-market sale of $113k MBVX by CHIEF FINANCIAL OFFICER, SECR. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.96 | 66,550 | $64K | 56.7% |
| 2 | $0.98 | 38,697 | $38K | 33.7% |
| 3 | $0.96 | 11,232 | $11K | 9.6% |
| Total | $0.97 avg | 116,479 | $113K | 100% |
| Filing → |
| MBVX | SELL | 2017-04-14 | $8K | — | Filing → |
| MBVX | SELL | 2017-04-11 | $2K | — | Filing → |
| MBVX | SELL | 2017-04-06 | $8K | — | Filing → |